|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Equity securities at fair value | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Securities held to maturity (fair value of $261,020 at June 30, 2026 and $282,830 at December 31, 2025) | ||||||||||||||||||||
| Federal Home Loan Bank and Federal Reserve Bank stock, at cost | ||||||||||||||||||||
| Loans held for sale, carried at fair value | ||||||||||||||||||||
| Loans held for sale, carried at lower of cost or fair value | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Mortgage | ||||||||||||||||||||
| Installment | ||||||||||||||||||||
| Total Loans | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Mortgage | ||||||||||||||||||||
| Installment | ||||||||||||||||||||
| Total allowance for credit losses | ||||||||||||||||||||
| Net Loans | ||||||||||||||||||||
| Other real estate and repossessed assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Capitalized mortgage loan servicing rights, carried at fair value | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Accrued income and other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Savings and interest-bearing checking | ||||||||||||||||||||
| Reciprocal | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Brokered time | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Subordinated debentures, net | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred stock, no par value, 200,000 shares authorized; none issued or outstanding | ||||||||||||||||||||
| Common stock, no par value, 500,000,000 shares authorized; issued and outstanding: 20,602,535 shares at June 30, 2026 and 20,548,893 shares at December 31, 2025 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
